| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.2M | +271.6% |
| SG&A Expense | $8.4M | +148.2% |
| Operating Income | -$18.7M | -203.5% |
| Interest Expense | $95K | +0.0% |
| Income Tax | $0 | -100.0% |
| Net Income | -$17.6M | -156.7% |
| EPS (Basic) | -$1.35 | -66.7% |
| EPS (Diluted) | -$1.35 | -66.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | -76.1% |
| Current Assets | $7.4M | -67.5% |
| Total Assets | $7.6M | -66.9% |
| Current Liabilities | $4.3M | +71.6% |
| Total Liabilities | $4.3M | +71.6% |
| Stockholders' Equity | $3.2M | -84.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.8M | -199.3% |
| Capital Expenditures | $101K | -60.4% |
| Investing Cash Flow | -$101K | +59.9% |
| Financing Cash Flow | $6K | -100.0% |
| Free Cash Flow | -$15.9M | -187.3% |